These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15795325)

  • 21. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents.
    Gruchalla KJ; Nawarskas JJ
    Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
    Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
    Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
    Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries.
    Seifert PS; Huibregtse BA; Polovick J; Poff B
    Cardiovasc Revasc Med; 2007; 8(4):251-8. PubMed ID: 18053947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstrating the influence of compression on artery wall mass transport.
    O'Connell BM; Walsh MT
    Ann Biomed Eng; 2010 Apr; 38(4):1354-66. PubMed ID: 20077008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy.
    Rizik DG; Klassen KJ
    Am J Cardiol; 2008 Nov; 102(9 Suppl):4J-11J. PubMed ID: 18928786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent implantation of sirolimus- and paclitaxel-eluting stents in the same vessel.
    Corbett SJ; Cosgrave J; Colombo A
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):109-14. PubMed ID: 17139626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous multivessel acute drug-eluting stent thrombosis.
    Garcia JA; Hansgen A; Casserly IP
    Int J Cardiol; 2006 Oct; 113(1):E11-5. PubMed ID: 17055601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry.
    Buszman P; Trznadel S; Milewski K; Rzeźniczak J; Przewłocki T; Kośmider M; Wójcik J; Janczak J; Zurakowski A; Kondys M; Król M; Kinasz L; Jaklik A; Rzeszutko Ł; Kałuza GL; Kiesz S; Gil R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):51-7. PubMed ID: 18098182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M; Finn AV; Farb A; Mont EK; Kolodgie FD; Ladich E; Kutys R; Skorija K; Gold HK; Virmani R
    J Am Coll Cardiol; 2006 Jul; 48(1):193-202. PubMed ID: 16814667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall.
    Bozsak F; Chomaz JM; Barakat AI
    Biomech Model Mechanobiol; 2014 Apr; 13(2):327-47. PubMed ID: 24395527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions.
    Aoki J; Ong AT; Rodriguez Granillo GA; McFadden EP; van Mieghem CA; Valgimigli M; Tsuchida K; Sianos G; Regar E; de Jaegere PP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Am Heart J; 2005 Nov; 150(5):994-9. PubMed ID: 16290984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.